Both miR-375 and its target genes, 14-3-3zeta and SP1, might be therapeutic targets, and either restoring miR-375 expression or abolishing expression of 14-3-3zeta and SP1 genes could diminish malignant cell behaviors and consequently block the progression of cancer. The gene discussed is SP1; the disease is cancer.